Chirogate International

Chirogate International is a specialized pharmaceutical company headquartered in Taiwan that focuses on the development and manufacture of Prostaglandin active pharmaceutical ingredients (APIs). Established in 1998, the company has become a prominent global supplier, providing high-quality APIs for ophthalmic, cardiovascular, and gastrointestinal applications. Their product portfolio includes widely used treatments such as Latanoprost, Bimatoprost, and Travoprost for glaucoma, as well as Lubiprostone for constipation. Chirogate operates advanced cGMP-compliant facilities and offers contract development and manufacturing (CDMO) services for complex organic synthesis. The company is recognized for its expertise in multi-step synthesis and chiral technology, serving major pharmaceutical markets worldwide including the United States, Europe, and Japan.